ADME TOX TECHNOLOGIES - An Exclusive Market Insight Report Update

ADME/Tox Technologies gives a market insight into products and services used in the ADME/Tox industry. Predictive technologies analyzed include In vivo, In vitro, and In silico.

Hyderabad, India (prHWY.com) May 4, 2012 - April 18, 2012 - RI Technologies' (http://www.researchimpact.com) report on ADME Tox Technologies gives a market insight into products and services used in the ADME Tox industry. Predictive technologies analyzed include In vivo, In vitro, and In silico. Related technologies such as High Throughput Screening (HTS), Laboratory Information Management System (LIMS), and cell based assays are also analyzed. Market projections and estimates are illustrated by region and by technology. The report serves as a guide to ADME Tox industry, covering more than 550 companies that are engaged in ADME Tox studies/screening, products and services. Major Contract Research Organizations, Research Institutes and Universities serving the ADME Tox industry are also covered in the corporate directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. Compilation of Worldwide Patents related to ADME Tox Technologies is also provided. A global perspective is presented along with regional analysis covering the regions of North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa with 103 exclusive graphically represented exhibits.

Global ADME Tox Technologies market is projected to grow at a robust rate of 14.9% compounded annually from 2005 through 2015. This growth is mainly driven by the efforts of pharmaceutical and biotech companies for reducing time and cost of drug discovery. ADME Tox profiling of a drug candidate plays a key role in reducing clinical trials cost and time of drug launch to the market. ADME Tox assays eliminate compounds with lack of bioavailability, lower efficacy and toxicity in early stages, in order to save time and costs in expensive later stages of drug discovery.

Due to ethical issues and growing trend towards decrease in using animals in clinical trials, there is a gradual decline in market for In vivo predictive technology. Though In vivo accounts for about three- fourth of total ADME Tox Technologies market currently, non-animal technologies- In vitro and In silico are projected to peg more than 40% of the market by 2015. In particular, In silico is projected to grow at a high CAGR during the period 2005-2015. In terms of technology, In silico is projected to register the fastest growth rate in all geographic markets. ADME Tox report is an ideal research tool providing strategic business intelligence to the corporate sector.

###

Tag Words: adme tox technologies

Categories: Biotech

Press Release Contact
http://www.researchimpact.com/MIR001_ADMETOXTECHNOLOGIES.aspx Customer Support: contactus@researchimpact.com.Call us at INDIA: +91 9676994272/UK: 076-24-057837 for your biotechnology

Link To This Press Release:

URL HTML Code